glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. “Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) Glucagon-like peptide 1 receptor agonist
Pay in 4 interest-free payments of $7.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
![glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) Glucagon-like peptide 1 receptor agonist](https://www.bmj.com/content/bmj/385/bmj-2023-078225/F1.large.jpg?download=true)
![glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) Glucagon-like peptide 1 receptor agonist](https://i.ytimg.com/vi/teq3D1c1XSA/hqdefault.jpg)
![glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) Glucagon-like peptide 1 receptor agonist](https://news.cuanschutz.edu/hubfs/Cancer%20Center/GLP-1%20and%20thyroid%20cancer.png)
















